How is GazetAI different from Apple News or Google News?

Other apps show you everything. GazetAI shows you only what matters — and analyzes each story across 19 dimensions before you even open it.

Why can't I just read the news myself?

The world publishes 2+ million articles every day. Reading them all at 250 words per minute would take 130 years — without sleeping. The average person sees about 0.0005% of what's published. GazetAI's AI reads everything and surfaces only the stories that actually matter to you.

Do I need to read the full article?

No. The AI summary and analysis dashboard give you the full picture in under a minute. Open the original only if you want to.

What does the free trial include?

Full access to 3 categories for 7 days. No charge unless you continue.

Can I cancel anytime?

Yes. Cancel from the app or your billing portal. You keep access until the end of your billing period.

What languages are supported?

9 languages: English, Spanish, French, German, Portuguese, Arabic, Japanese, Chinese, Russian. Every analysis is fully translated.

Where do the news come from?

We aggregate from 50,000+ professional sources, then enrich every article with our AI pipeline.

← All Sports news

Cody Durden gets new opponent for UFC 329

2 min read

Cody Durden will face Alessandro Costa at UFC 329 in Las Vegas on July 11 after his original opponent, Ode' Osbourne, pulled out; multiple sources confirmed the booking to Heavy.com following Durden's Instagram announcement. Durden, a UFC competitor since 2020 who is preparing for his 17th walk to the Octagon, recently snapped a four-fight skid by beating Jafel Filho and is known for taking short-notice fights. Costa, in the UFC since 2022, takes the fight on two weeks' notice and arrives with two TKO finishes this year, putting both men within reach of the division rankings.

Cody Durden will face Alessandro Costa at UFC 329.

The full analysis

19 dimensions on this story — world impact, market read, and what happens next.

Full ContextLocked
Affected SectorsLocked
Stock ImpactLocked
Investor RelevanceLocked
Professional RelevanceLocked
Watch PointsLocked
Probability of ChangeLocked
Debate PointsLocked
Historical ParallelLocked
Follow-up QuestionsLocked
Pros & ConsLocked

Start your 7-day free trial